Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 3 ( March, 2022 ) > List of Articles

CASE SERIES

Cytomegalovirus Coinfection in Critically Ill Patients with Novel Coronavirus-2019 Disease: Pathogens or Spectators?

Suhail S Siddiqui, Soumyadip Chatterjee, Ambuj Yadav, Nitin Rai, Avinash Agrawal, Geeta Yadav, Shantanu Prakash, Amit Kumar, Syed N Muzaffar

Keywords : Coronavirus disease-2019, Critically ill, Cytomegalovirus, Viral coinfection

Citation Information : Siddiqui SS, Chatterjee S, Yadav A, Rai N, Agrawal A, Yadav G, Prakash S, Kumar A, Muzaffar SN. Cytomegalovirus Coinfection in Critically Ill Patients with Novel Coronavirus-2019 Disease: Pathogens or Spectators?. Indian J Crit Care Med 2022; 26 (3):376-380.

DOI: 10.5005/jp-journals-10071-24130

License: CC BY-NC 4.0

Published Online: 30-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Coronavirus disease-2019 (COVID-19) pandemic is raging all over the world. As we are delving more into management of COVID-19, certain new challenges are emerging. One of these is emergence or reactivation of viral infections belonging to Herpesviridae family, especially cytomegalovirus (CMV). Although we have come across the threat of fungal and resistant bacterial infections, experience regarding reactivation or coinfection with concomitant viral infections like CMV during the COVID pandemic is still limited. Whether CMV is a bystander or pathogen is difficult to say categorically and needs further research. In this case series, we intend to describe three patients of COVID-19 with CMV coinfections. To our knowledge, this is the first case series from India.


HTML PDF Share
  1. Kayarat B, Khanna P, Sarkar S. Superadded coinfections and antibiotic resistance in the context of COVID-19: where do we stand? Indian J Crit Care Med 2021;25(6):699–703. DOI: 10.5005/jp-journals-10071-23855.
  2. Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 2020;27(6):992–1000.e3. DOI: 10.1016/j.chom.2020.04.009.
  3. Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol 2021;19(12):759–773. DOI: 10.1038/s41579-021-00582-z.
  4. Moss P. “The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection? Immun Ageing 2020;17(1):1–6. DOI: 10.1186/s12979-020-00185-x.
  5. D'Ardes D, Boccatonda A, Schiavone C, Santilli F, Guagnano MT, Bucci M, et al. A case of coinfection with SARS-COV-2 and cytomegalovirus in the era of COVID-19. Eur J Case Rep Intern Med 2020;7(5):001652. DOI: 10.12890/2020_001652.
  6. Le Balc'h P, Pinceaux K, Pronier C, Seguin P, Tadié JM, Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care 2020;24(1):1–3. DOI: 10.1186/s13054-020-03252-3.
  7. Moniz P, Brito S, Póvoa P. SARS-CoV-2 and cytomegalovirus co-infections–a case series of critically ill patients. J Clin Med 2021;10(13):2792. DOI: 10.3390/jcm10132792.
  8. Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now 2021;51(3):296–299. DOI: 10.1016/j.idnow.2021.01.005.
  9. Khan FY, Morad NA. Cytomegalovirus enteritis in a mechanically ventilated patient with chronic obstructive pulmonary disease. Indian J Crit Care Med 2006;10(1):40–43. DOI: 10.4103/0972-5229.24689.
  10. Amiya S, Hirata H, Shiroyama T, Adachi Y, Niitsu T, Noda Y, et al. Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19. Respirol Case Rep 2021;9(7):e00801. DOI: 10.1002/rcr2.801.
  11. de Melo Silva J, Pinheiro-Silva R, Dhyani A, Pontes GS. Cytomegalovirus and Epstein-Barr infections: prevalence and impact on patients with hematological diseases. BioMed Res Int 2020;2020:1627824. DOI: 10.1155/2020/1627824.
  12. Dandu H, Yadav G, Malhotra HS, Pandey S, Sachu R, Dubey K. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: a bone marrow study. Int J Lab Hematol 2021;43(6):1291–1301. DOI: 10.1111/ijlh.13619.
  13. Caliendo AM. Approach to the diagnosis of cytomegalovirus infection. Available from: https://www.uptodate.com/contents/approach-to-the-diagnosis-of-cytomegalovirus-infection?source¼search_result&search¼CMV%20diagnosis&selectedTitle¼2~150 [Literature review current through: October 2021].
  14. Al-Omari A, Aljamaan F, Alhazzani W, Salih S, Arabi Y. Cytomegalovirus infection in immunocompetent critically ill adults: literature review. Ann Intensive Care 2016;6(1):110. DOI: 10.1186/s13613-016-0207-8.
  15. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009;13(3):R68. DOI: 10.1186/cc7875.
  16. Papazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S, et al. Comegalovirus reactivation in ICU patients. Intensive Care Med 2016;42(1):28–37. DOI: 10.1007/s00134-015-4066-9.
  17. Papazian L, Jaber S, Hraiech S, Baumstarck K, Cayot-Constantin S, Aissaoui N, et al. Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation. Ann Intensive Care 2021;11(1):33. DOI: 10.1186/s13613-020-00793-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.